57 |
NetworkNewsBreaks Oncotelic Therapeutics, |
NetworkNewsWire |
09/18/2025 5:00:56 PM |
56 |
Oncotelic Therapeutics Inc. (OTLC) Champions |
NetworkNewsWire |
09/17/2025 5:38:54 PM |
55 |
Advancing Cancer Research Brings New Hope for |
NetworkNewsWire |
09/17/2025 5:34:26 PM |
54 |
NetworkNewsBreaks Oncotelic Therapeutics, |
NetworkNewsWire |
09/16/2025 3:45:44 PM |
53 |
NetworkNewsBreaks Oncotelic Therapeutics, |
NetworkNewsWire |
09/12/2025 4:06:51 PM |
52 |
NetworkNewsBreaks Oncotelic Therapeutics, |
NetworkNewsWire |
09/10/2025 3:33:58 PM |
51 |
NetworkNewsBreaks Oncotelic Therapeutics, |
NetworkNewsWire |
09/04/2025 3:55:55 PM |
50 |
Oncotelic Therapeutics Inc. (OTLC) Is One to |
NetworkNewsWire |
09/03/2025 4:50:42 PM |
49 |
NetworkNewsBreaks Oncotelic Therapeutics, |
NetworkNewsWire |
08/28/2025 4:29:58 PM |
48 |
Oncotelic Announces Release of Pet2DAO Tokens |
panda448 |
04/05/2023 8:42:29 PM |
47 |
Oncotelic Awarded BARDA Funding for Development |
panda448 |
10/17/2022 6:48:26 PM |
46 |
Oncotelic Announces Pipeline Presentation and IPO |
panda448 |
06/15/2022 5:04:02 PM |
45 |
ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS |
panda448 |
05/23/2022 1:25:35 PM |
44 |
Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as |
panda448 |
05/04/2022 1:04:13 PM |
43 |
Oncotelic Appoints Seymour Fein M.D. as Chief |
panda448 |
05/04/2022 1:04:02 PM |
42 |
Oncotelic; Announcing Successful Joint Venture |
panda448 |
04/04/2022 4:19:15 PM |
41 |
Oncotelic presentation at MedInvest |
panda448 |
04/01/2022 2:21:28 PM |
40 |
Oncotelic JV Financing: |
panda448 |
03/21/2022 3:48:37 PM |
39 |
Oncotelic; Looking at Industry Comparison for the |
panda448 |
03/15/2022 7:42:49 PM |
38 |
Oncotelic; Discussing the Company's Development |
panda448 |
03/15/2022 7:40:57 PM |
37 |
Oncotelic; Diving into the Company's Outlook for |
panda448 |
03/15/2022 7:40:43 PM |
36 |
Oncotelic to Present New Studies on its TGF- |
panda448 |
03/10/2022 2:17:44 PM |
35 |
Oncotelic; An Introduction to CFO Amit Shah & His |
panda448 |
03/02/2022 6:00:46 PM |
34 |
Oncotelic Initiates Phase 1 Trial Evaluating CA4P |
panda448 |
01/05/2022 11:37:47 AM |
33 |
Oncotelic Announces that ORF8 Mutations are |
panda448 |
12/22/2021 11:34:33 AM |
32 |
Oncotelics Dr. Anthony Maida to Present at 2nd |
panda448 |
12/14/2021 12:07:13 PM |
31 |
Mesothelioma Clinical Trial to Involve Drug |
panda448 |
12/08/2021 7:37:25 PM |
30 |
Oncotelic 2021 Q3 Report, Litchfield reiterates |
panda448 |
12/07/2021 6:44:09 PM |
29 |
Biotech Growth Stocks Set to Benefit from Rising |
panda448 |
12/03/2021 7:26:03 PM |
28 |
New Oncotelic Therapeutics Inc (OTLC) Stock |
panda448 |
11/29/2021 6:33:47 PM |
27 |
Oncotelic Therapeutics Inc (OTLC) stock news and |
panda448 |
11/22/2021 7:55:18 PM |
26 |
Oncotelic Announces Successful Completion of |
panda448 |
11/16/2021 9:27:46 AM |
25 |
Another TGF-beta acquisition- bode well for |
panda448 |
11/10/2021 5:47:11 PM |
24 |
$OTLC in immunotherapy space: Immunotherapy |
panda448 |
11/05/2021 7:56:33 PM |
23 |
ONCOTELIC ANNOUNCES UPDATE ON THE OT-101 CLINICAL |
panda448 |
10/22/2021 8:15:01 PM |
22 |
ONCOTELIC ACQUIRES FAST TO MARKET LATE-STAGE DRUG |
panda448 |
10/05/2021 6:19:24 PM |
21 |
OT-101 an antisense against TGF-2 for |
panda448 |
09/29/2021 8:17:18 PM |
20 |
ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE |
panda448 |
09/07/2021 6:46:29 PM |
19 |
PULMOHEAL/ ARTIVEDA IS CLINICALLY ACTIVE |
panda448 |
09/07/2021 6:45:04 PM |
18 |
ONCOTELIC AND GOLDEN MOUNTAIN PARTNERS FORMING A |
panda448 |
08/16/2021 7:04:07 PM |
17 |
New 8-K |
CaptnAmerca |
07/20/2021 10:31:08 AM |
16 |
ONCOTELIC CLOSES COVID-19 CLINICAL TRIAL EARLY |
CaptnAmerca |
06/15/2021 9:24:41 AM |
15 |
Mateon Therapeutics Inc. has changed its name to |
panda448 |
03/31/2021 3:24:28 PM |
14 |
Litchfield Hills upgrade price target to $4 from |
panda448 |
03/05/2021 2:04:49 PM |
13 |
MATEON THERAPEUTICS AND WINDLAS BIOTECH PUBLISH |
panda448 |
03/03/2021 8:41:37 PM |
12 |
MATEON PARTNERED WITH CHOPRA FOUNDATION ON |
panda448 |
02/16/2021 6:04:51 PM |
11 |
Targeting TGF-b pathway with COVID-19 Drug |
panda448 |
02/01/2021 6:05:26 PM |
10 |
MATEON LAUNCHING MOBILE APP, ARTIHEALTH, FOR |
panda448 |
01/26/2021 8:15:48 PM |
9 |
Zacks Small Cap Research: MATN: POSITIVE INTERIM |
panda448 |
01/14/2021 7:25:15 PM |
8 |
MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM |
panda448 |
01/13/2021 2:35:51 PM |